Search

everythinglearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

The cryogel effectively heals infected wounds and promotes tissue regeneration without scarring.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Enterococcus faecalis delays wound healing by disrupting cell functions and creating an anti-inflammatory environment.

Hair is important for aging and cancer treatment, affecting emotions, culture, and health.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

Keratin 16 delays skin maturation and affects skin and hair development in mice.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Erlotinib can cause excessive eyelash growth.

EGF controls hair growth by regulating hair follicles' growth phases.

Tideglusib helps heal wounds in older skin.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

Lithium chloride-treated stem cell exosomes boost hair growth by activating a specific pathway.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

Increasing calcium sensing receptor speeds up skin and hair development in mice.